SAN DIEGO, CA, Jan 4, 2022 (GLOBE NEWSWIRE) – via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first publicly traded cannabis company in the United States to launch the first cannabis-derived products, brands, and supply chain, today announced that its subsidiary Kannaway® Japan It had the best revenue month in the company’s history in December 2021.
According to Research and Markets, the global CBD oil market is expected to reach $5.3 billion by 2025 With Asia Pacific as one of the fastest growing regions.
“As we head off into 2022 stronger than ever, I am very proud to end 2021 in good shape by achieving this milestone and expanding our reach,” said Blake Schroeder, CEO of Kannaway. “Sales in Japan continue to grow and we look forward to continued growth in the region.”
To learn more about Kannaway®, please visit the company online at https://www.kannaway.com/.
About Kannaway®
Kannawi® is a network sales and marketing company specializing in the sale and marketing of plant based cannabis products. Currently, Kannaway® hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity for sales professionals who wish to become successful leaders in the sale and marketing of plant-based, hemp-based products.
About Medical Marijuana, Inc.
We are Firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company comprising three distinct business units in the non-psychoactive cannabis space: a global group of cannabis-based food brands led by Kannawi® And HempMeds®; A leader in sourcing high-quality, legal, non-psychoactive cannabis products derived from industrial hemp; and the sector of cannabis-based clinical research and development of botanical medicines led by pharmaceutical investment firms and partners including AXIM® Biotechnologies, Inc. And Neuropathics. Medical Marijuana, Inc. was selected. As the best CBD product ever CNBC. Medical Marijuana, Inc. Also the first company to obtain historic import permits for CBD products from the governments of Brazil, Mexico, Argentina and Paraguay and is a pioneer in developing international markets. The company’s main product Real scientific hemp oil It has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.
Medical Marijuana, Inc. is headquartered in. In San Diego, California, additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To watch a video of Medical Marijuana, Inc. , click here.
Forward-looking disclaimer
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the safe harbor law created by those sections. This material contains statements about expected future events and/or financial results of a forward-looking nature and subject to risks and uncertainties. These forward-looking statements by definition include risks, uncertainties and other factors, which could cause Medical Marijuana, Inc.’s actual results, performance or achievements to differ. materially from the data contained herein.
Disclosure by the Food and Drug Administration (FDA)
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Legal Disclosure
Medical Marijuana, Inc. does not. Selling or distributing any products that violate the Controlled Substances Act in the United States.